Affiliation:
1. Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033,1 and
2. Department of Pathology, Case Western Reserve University, Cleveland, Ohio 441062
Abstract
ABSTRACT
The activities of levofloxacin and clarithromycin against 199 penicillin- and macrolide-susceptible and -resistant pneumococci were tested by agar and microdilution methods in air and by disk diffusion and E-test methods in air and CO
2
. For levofloxacin, ≥99.0% of strains were susceptible at ≤2.0 μg/ml with zone diameters of ≥17 mm, regardless of incubation in air or CO
2
. Although zone sizes were smaller and E-test MICs were higher for clarithromycin in CO
2
than those in air, category differences were minor, and susceptibility rates for clarithromycin were similar to those obtained by agar and microdilution in air (range, 76.9 to 80.9% by all methods). For clarithromycin, adjustment of breakpoints based upon distribution of results resulted in susceptibility rates which were similar by all methods (75.8 to 76.9% susceptible, 0 to 1.5% intermediate, 22.6 to 23.1% resistant). Minor discrepancies were obtained with levofloxacin for one strain (0.5%) by microdilution and two strains (1.0%) by disk diffusion in CO
2
. For clarithromycin, minor discrepancies were found in three strains (1.5%) by microdilution, seven strains (3.5%) by agar dilution, four strains (2.0%) by E-test in air, six strains (3.0%) by disk diffusion in air, and five strains (2.5%) by disk diffusion in CO
2
. Major discrepancies occurred with levofloxacin in one strain (0.5%) by microdilution but were not found with clarithromycin. Very major discrepancies were not seen with levofloxacin, but occurred with clarithromycin in five strains (2.5%) by microdilution, three strains (1.5%) by agar dilution, two strains (1.0%) by E-test in air, eight strains (4.0%) by disk diffusion in air, and one strain (0.5%) by disk diffusion in CO
2
.
Publisher
American Society for Microbiology
Reference19 articles.
1. Antimicrobial resistance in Streptococcus pneumoniae—an overview;Appelbaum P. C.;Clin. Infect. Dis.,1992
2. Drug-resistant Streptococcus pneumoniae—Kentucky and Tennessee, 1993;Block S.;Morbid. Mortal. Weekly Rep.,1994
3. Bolmstrom
A.
Karlsson
C.
The influence of CO 2 incubation on MICs of quinolones tested with S. pneumoniae and H. influenzae abstr. D-35
Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy.
1997
89
American Society for Microbiology
Washington D.C
4. Emergence of drug-resistant pneumococcal infections in the United States;Breiman R. F.;JAMA,1994
5. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献